25651 Atlantic Ocean Drive
Lake Forest, CA 92630
United States
626 303 7902
https://www.staar.com
Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 1.056
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Thomas G. Frinzi | President, CEO & Chairman | 1,22M | N/D | 1956 |
Mr. Patrick F. Williams | Chief Financial Officer | 746,92k | N/D | 1973 |
Mr. Warren Foust | Chief Operating Officer | 666,81k | N/D | 1976 |
Dr. Keith Holliday Ph.D. | Chief Technology Officer | 679,29k | N/D | 1963 |
Dr. Scott D. Barnes M.D. | Chief Medical Officer | 691,15k | N/D | 1963 |
Mr. Brian Moore | Vice President of Investor Relations & Corporate Development | N/D | N/D | N/D |
Mr. Nathaniel B. Sisitsky Esq. | General Counsel & Corporate Secretary | N/D | N/D | 1974 |
Mr. James Francese | Senior Vice President of Commercial Operations - North America & APAC | 755,65k | 882,3k | 1964 |
Dr. Magda Michna Ph.D. | Chief Clinical, Regulatory & Medical Affairs Officer | N/D | N/D | N/D |
Mr. Robert Studholme | Senior Vice President of Operations | N/D | N/D | 1953 |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
L'ISS Governance QualityScore di STAAR Surgical Company al 29 aprile 2024 è 4. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 6; diritti degli azionisti: 7; retribuzione: 4.